No matter what pharmaceutical companies do, they just can’t win. Everyone wants the cures and the miracles from drug innovation, but no one wants to pay for them. And why is there an entitlement attitude when it comes to health and drug innovation, but not other forms of technological breakthroughs? IPI’s Merrill Matthews and Tom Giovanetti discuss this and more, especially in light of the recent Ebola outbreak, as well as the new Hepatitis C drug Sovaldi.
2014 08 15 IPI Podcast Drug Innovation Ebola